Mutations in low-grade serous ovarian cancer and response to BRAF and MEK inhibitors

被引：0
|
作者：
Moujaber, Tania [1 ]
Etemadmoghadam, Dariush [2 ]
Mapagu, Cristina [1 ]
Kennedy, Catherine [1 ]
Chiew, Yoke-Eng [1 ]
Kan, Casina [1 ]
Nevins, Nikilyn [1 ]
Srirangan, Sivatharsny [1 ]
Fereday, Sian [2 ]
Traficante, Nadia [2 ]
Bowtell, David [2 ]
Balleine, Rosemary [3 ]
Harnett, Paul [4 ]
deFazio, Anna [1 ]
机构：
[1] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia
[2] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Univ Sydney, Childrens Med Res Inst, Sydney, NSW, Australia
[4] Univ Sydney, Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2584
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition
    Moujaber, Tania
    Etemadmoghadam, Dariush
    Kennedy, Catherine J.
    Chiew, Yoke-Eng
    Balleine, Rosemary L.
    Saunders, Catherine
    Wain, Gerard, V
    Gao, Bo
    Hogg, Russell
    Srirangan, Sivatharsny
    Kan, Casina
    Fereday, Sian
    Traficante, Nadia
    Patch, Ann-Marie
    Pearson, John, V
    Waddell, Nicola
    Grimmond, Sean M.
    Dobrovic, Alexander
    Bowtell, David D. L.
    Harnett, Paul R.
    DeFazio, Anna
    Bowtell, D.
    Chenevix-Trench, G.
    Green, A.
    Webb, P.
    DeFazio, A.
    Gertig, D.
    Traficante, N.
    Fereday, S.
    Moore, S.
    Harrap, K.
    Sadkowsky, T.
    Pandeya, N.
    Hung, J.
    Malt, M.
    Alexander, B.
    Ashover, E.
    Brown, S.
    Corrish, T.
    Green, L.
    Jackman, L.
    Ferguson, K.
    Martin, K.
    Martyn, A.
    Ranieri, B.
    Mellon, A.
    Robertson, R.
    Vanden Bergh, T.
    Jones, M.
    Mackenzie, P.
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 14
  • [2] Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors
    Kulkarni, Anjali
    Cooke, Carly
    Fazelzad, Rouhi
    Fung-Kee-Fung, Michael
    May, Taymaa
    Zigras, Tiffany
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (01): : 11 - 16
  • [3] Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma
    Tholander, Bengt
    Koliadi, Anthoula
    Botling, Johan
    Dahlstrand, Hanna
    Von Heideman, Anne
    Ahlstrom, Hakan
    Oberg, Kjell
    Ullenhag, Gustav J.
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2020, 125 (04) : 325 - 329
  • [4] Targeting BRAF pathway in low-grade serous ovarian cancer
    Perrone, Chiara
    Angioli, Roberto
    Luvero, Daniela
    Giannini, Andrea
    Di Donato, Violante
    Cuccu, Ilaria
    Muzii, Ludovico
    Raspagliesi, Francesco
    Bogani, Giorgio
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (04)
  • [5] In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours
    Sieben, NLG
    Macropoulos, P
    Roemen, GM
    Kolkman-Uljee, SM
    Fleuren, GJ
    Houmadi, R
    Diss, T
    Warren, B
    Al Adnani, M
    de Goeij, AP
    Krausz, T
    Flanagan, AM
    JOURNAL OF PATHOLOGY, 2004, 202 (03): : 336 - 340
  • [6] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    MODERN PATHOLOGY, 2003, 16 (01) : 211A - 211A
  • [7] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    LABORATORY INVESTIGATION, 2003, 83 (01) : 211A - 211A
  • [8] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) : 484 - 486
  • [9] MEK inhibition for low-grade serous ovarian cancer: are we there yet?
    Scaranti, Mariana
    Mathias-Machado, Maria Cecilia
    Guo, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 155 - 156
  • [10] MEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype
    Gershenson, David M.
    Gourley, Charlie
    Paul, James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3731 - +
12345